Viatris VTRS
NASDAQ VTRS
$16.54 -0.07 (-0.43%)
As of: Sep 9, 2026 · 12:08 PM EDT

Viatris (VTRS) Revenue (2019 - 2026)

Viatris (VTRS) posted Revenue of $3.8 billion for Q2 2026, up 6.82% on a QoQ basis from $3.5 billion in Q1 2026, and up 4.88% year-over-year from $3.6 billion in Q2 2025.

Analysis

Viatris (VTRS) Revenue (2019 - 2026) Analysis & Trends

Viatris has reported Revenue for 8 years, with the latest figure at $3.8 billion in Q2 2026.

  • On a quarterly basis, Revenue rose 4.88% year-over-year to $3.8 billion in Q2 2026; TTM through Jun 2026 was $14.7 billion, a 4.4% increase from a year earlier, with the FY2025 full-year figure at $14.3 billion, down 2.98% from the prior year.
  • Revenue was $3.8 billion for Q2 2026 at Viatris, up from $3.5 billion in the prior quarter.
  • The five-year high for Revenue was $4.2 billion in Q1 2022, with the low at $3.3 billion in Q1 2025.
  • Average Revenue over 5 years is $3.8 billion, with a median of $3.8 billion recorded in 2025.
  • The sharpest annual moves came in 2025 and 2026: Revenue decreased 11.17% in 2025, then grew 8.07% in 2026.
  • Over 5 years, Revenue stood at $3.9 billion in 2022, then declined by 1.0% to $3.8 billion in 2023, then slipped by 8.06% to $3.5 billion in 2024, then climbed by 4.97% to $3.7 billion in 2025, then increased by 1.44% to $3.8 billion in 2026.
  • The last three Revenue figures came in at $3.8 billion (Q2 2026), $3.5 billion (Q1 2026), and $3.7 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Teva Pharmaceutical Industries 42.90 Bn 39.24 Bn 2.15 Bn 4.14 Bn
2 Viatris 19.25 Bn 18.36 Bn 1.46 Bn 3.76 Bn
3 Dr Reddys Laboratories 9.86 Bn 9.69 Bn 396.53 Mn 852.47 Mn
4 Amneal Pharmaceuticals 5.52 Bn 5.39 Bn 334.51 Mn 796.20 Mn
5 Bausch Health Companies 2.38 Bn 537.63 Mn 2.10 Bn 2.85 Bn
6 Alvotech 1.49 Bn 1.35 Bn 2.56 Mn 54.76 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 266.04 Mn
8 Amphastar Pharmaceuticals 995.52 Mn 705.40 Mn 93.47 Mn 183.90 Mn
9 Fennec Pharmaceuticals 410.05 Mn 368.80 Mn 17.15 Mn 17.87 Mn
10 RedHill Biopharma 179.93 Mn 179.93 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.76 Bn
Mar 31, 2026 3.52 Bn
Dec 31, 2025 3.70 Bn
Sep 30, 2025 3.76 Bn
Jun 30, 2025 3.58 Bn
Mar 31, 2025 3.25 Bn
Dec 31, 2024 3.53 Bn
Sep 30, 2024 3.75 Bn
Jun 30, 2024 3.80 Bn
Mar 31, 2024 3.66 Bn
Dec 31, 2023 3.84 Bn
Sep 30, 2023 3.94 Bn
Jun 30, 2023 3.92 Bn
Mar 31, 2023 3.73 Bn
Dec 31, 2022 3.88 Bn
Sep 30, 2022 4.08 Bn
Jun 30, 2022 4.12 Bn
Mar 31, 2022 4.19 Bn
Dec 31, 2021 4.34 Bn
Sep 30, 2021 4.54 Bn